Table 2.
Participants’ medication at the day of assessment
| Subject | Days of antipsychotic | Antipsychotic | Dose (mg) | Duration (days) | Defined daily dose (DDD) |
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 |
| 2 | 0 | 0 | 0 | 0 | 0 |
| 3 | 7 | Paliperidone | 6 | 7 | 7 |
| 4 | 0 | 0 | 0 | 0 | 0 |
| 5 | 7 | Aripiprazole | 5 | 7 | 2.6 |
| 6 | 0 | 0 | 0 | 0 | 0 |
| 7 | 0 | 0 | 0 | 0 | 0 |
| 8 | 0 | 0 | 0 | 0 | 0 |
| 9 | 7 | Paliperidone | 3, 6 | 3, 4 | 5.5 |
| 10 | 0 | Olanzapine | 10 | 1 | 1 |
| 11 | 0 | 0 | 0 | 0 | 0 |
| 12 | 5 | Risperidone | 1.5 | 5 | 1.5 |
| 13 | 0 | 0 | 0 | 0 | 0 |
| 14 | 7 | Olanzapine | 7.5 | 7 | 5.25 |
| 15 | 0 | 0 | 0 | 0 | 0 |
| 16 | 0 | 0 | 0 | 0 | 0 |
| 17 | 0 | 0 | 0 | 0 | 0 |
| 18 | 7 | Risperidone | 1 | 7 | 1.4 |
| 19 | 10 | Aripiprazole | 5 | 10 | 3.333 |